Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE5A | O76074 | 9/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | GMNN | O75496 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
| ▸ | GFER | P55789 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5118969 | 0.93 | PDE5A (0.71) | PDE5AALDH1A1LMNAKDM4ENPC1 | |
| SCHEMBL5110534 | 0.87 | PDE5A (0.67) | PDE5AALDH1A1LMNAKDM4ENPC1 | |
| SCHEMBL16267521 | 0.84 | PDE5A (0.71) | PDE5AALDH1A1LMNAKDM4ENPC1 | |
| SCHEMBL5104788 | 0.84 | PDE5A (0.72) | PDE5AALDH1A1LMNAKDM4ENPC1 | |
| SCHEMBL5107975 | 0.83 | PDE5A (0.85) | PDE5AALDH1A1LMNAKDM4ENPC1 | |
| SCHEMBL5138807 | 0.82 | PDE5A (0.70) | PDE5AALDH1A1LMNAKDM4ENPC1 | |
| SCHEMBL5107243 | 0.82 | PDE5A (0.53) | PDE5AALDH1A1LMNAKDM4ENPC1 | |
| SCHEMBL3081769 | 0.82 | PDE5A (0.76) | PDE5AALDH1A1LMNAKDM4ENPC1 | |
| SCHEMBL5140293 | 0.82 | PDE5A (0.60) | PDE5AALDH1A1LMNAKDM4ENPC1 | |
| SCHEMBL5111298 | 0.81 | PDE5A (0.50) | PDE5AALDH1A1LMNAKDM4ENPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7378532-B2 | Fused pyrazolyl compound | YUNG SHIN PHARMACEUTICAL IND. CO., LTD. (TW) | 2008-05-27 | — | — | US | claimed |
| EP-1586572-A1 | Fused pyrazolyls as anti-cancer drugs | Yung Shin Pharm. Ind. Co. Ltd. (TW) | 2005-10-19 | — | — | EP | claimed |
| US-20050215612-A1 | Novel fused pyrazolyl compound | YUNG SHIN PHARMACEUTICAL IND. CO., LTD. (TW) | 2005-09-29 | — | — | US | claimed |
| US-7378532-B2 | Fused pyrazolyl compound | YUNG SHIN PHARMACEUTICAL IND. CO., LTD. (TW) | 2008-05-27 | — | — | US | disclosed |
| EP-1586572-A1 | Fused pyrazolyls as anti-cancer drugs | Yung Shin Pharm. Ind. Co. Ltd. (TW) | 2005-10-19 | — | — | EP | disclosed |
| US-20050215612-A1 | Novel fused pyrazolyl compound | YUNG SHIN PHARMACEUTICAL IND. CO., LTD. (TW) | 2005-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050215612-A1 | Novel fused pyrazolyl compound | AR, ARL1, NR5A2 | PDE5A 2742/4885ALDH1A1 1869/4885LMNA 4140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.